iSpecimen (ISPC) Cost of Revenue (2020 - 2026)

iSpecimen (ISPC) has reported Cost of Revenue for 7 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cost of Revenue rose 344.29% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $3.3 million (down 21.98% YoY), while the FY2025 annual figure was $2.3 million, down 55.09% from the prior year.
• Cost of Revenue came in at $1.5 million for Q1 2026 at iSpecimen, up from $1.1 million in the prior quarter.
• The five-year high for Cost of Revenue was $1.6 million in Q3 2024, with the low at $204593.0 in Q3 2025.
• Average Cost of Revenue over 5 years is $932281.2, with a median of $962169.0 recorded in 2023.
• Across the five-year window, Cost of Revenue tumbled 86.84% in 2025 and soared 344.29% in 2026, its largest moves.
• Year by year, Cost of Revenue stood at $914725.0 in 2022, then sank by 38.46% to $562895.0 in 2023, then jumped by 126.73% to $1.3 million in 2024, then fell by 11.22% to $1.1 million in 2025, then soared by 36.11% to $1.5 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $1.5 million, $1.1 million, and $204593.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.